scispace - formally typeset
R

Rafael Elias Marques

Researcher at Universidade Federal de Minas Gerais

Publications -  51
Citations -  2271

Rafael Elias Marques is an academic researcher from Universidade Federal de Minas Gerais. The author has contributed to research in topics: Medicine & Flavivirus. The author has an hindex of 20, co-authored 37 publications receiving 1411 citations. Previous affiliations of Rafael Elias Marques include Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

TL;DR: Targeting HIF-1α-induced changes in monocyte metabolism by SARS-CoV-2 infection directly inhibit T cell response and reduce epithelial cell survival, and may have great therapeutic potential for the development of novel drugs to treat COVID-19.
Journal ArticleDOI

The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.

TL;DR: In line with its in vitro anti-ZIKV activity, 7DMA reduced viremia and delayed virus-induced morbidity and mortality in infected mice, which validates this small animal model to assess the in vivo efficacy of novel ZIKV inhibitors.
Journal ArticleDOI

Targeting CCL5 in inflammation

TL;DR: Overall, it is not likely that specific targeting of CCL5 will result in new adjunct strategies for the treatment of infectious diseases with a major inflammatory component, but targeting CCR5 could result in novel therapies for chronic inflammatory diseases, where it may decrease inflammatory responses and fibrosis, and certain solid tumors,where it may have a role in angiogenesis.